Identifying the pathways involved in the apoptotic cell death that is associated with polymyxin-induced nephrotoxicity is crucial for the development of strategies to ameliorate this dose-limiting side effect and for the development of novel safer polymyxins. The primary aim of this study was to identify the major pathways which lead to polymyxin-induced apoptosis in cultured rat kidney proximal tubular cells (NRK-52E). Caspase-3, -8, and -9 were activated by polymyxin B treatment in a concentrationdependent manner. Concentration-and time-dependent expression of FasL and deformation of mitochondrial morphology were revealed following polymyxin B treatment. The proportion of cells with filamentous mitochondria (regular morphology) following an 8-h treatment with 1.0 mM polymyxin B was 56.2% ؎ 9.7% (n ‫؍‬ 3). This was decreased to 30.7% ؎ 7.5% when the polymyxin B concentration was increased to 2.0 mM. The mitochondrial membrane potential (⌬ m ) decreased to 14.1% ؎ 2.9% in the cells treated with 1.0 mM polymyxin B for 24 h (n ‫؍‬ 3) compared to that in the untreated control group. Concomitantly, concentration-and time-dependent production of mitochondrial superoxide was also observed. This study is the first to have demonstrated that polymyxin-induced apoptosis is mediated through both the death receptor and mitochondrial pathways in cultured renal tubular cells. It provides key information not only for the amelioration of polymyxin-induced nephrotoxicity but also for the discovery of novel safer polymyxin-like antibiotics against Gram-negative "superbugs."
G
ram-negative "superbugs" that are resistant to almost all current antibiotics have become a major global medical challenge. In particular, Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae are common Gram-negative pathogens causing life-threatening infections in critically ill and immunocompromised patients (1) . Most worryingly, many clinical isolates have become resistant to all antibiotics except polymyxin B and polymyxin E (colistin) (2) . Unfortunately, there are virtually no new antibiotics against these difficult-to-treat Gramnegative pathogens in the drug discovery pipeline (3, 4) . Therefore, polymyxin B and colistin are a precious therapeutic resource in the uphill battle against these very problematic human pathogens.
Notwithstanding their excellent antibacterial activity, the Achilles' heel of the polymyxins is their dose-limiting nephrotoxicity. Pharmacological data generated by our group indicate that plasma concentrations achieved with the currently recommended dosage regimens are suboptimal in many patients; potentially leading to poor clinical outcome and emergence of resistance (5) (6) (7) . Simply increasing the daily dose of polymyxins is not an option because of nephrotoxicity, which occurs in up to ϳ60% of patients (5, 8) . The renal handling mechanisms of polymyxins almost certainly contribute to their propensity for causing kidney tubular cell damage. We have demonstrated that colistin and polymyxin B undergo very avid tubular reabsorption (6, 9, 10) . Polymyxin-induced nephrotoxicity presents as acute apoptotic tubular cell death, cell cycle arrest, decreased urine output, and increased serum creatinine concentration (11) (12) (13) . In a recent clinical study, polymyxin-induced tubular cell toxicity was suggested from both the microscopic analysis of urine samples and the time course of renal recovery (14) . Importantly, substantial intracellular accumulation of polymyxins has been discovered by employing synchrotron X-ray fluorescence microscopy and it is highly likely that this accumulation leads to cellular toxicity (15) .
The accumulation of polymyxins in kidney tubular cells may be mediated through the endocytic receptor megalin and other transporters (10, 16) . In many mammalian cells, drug-induced apoptotic cell death is regulated by the death receptor-and mitochondrion-mediated pathways (17) (18) (19) . The present study aimed to identify the major apoptotic pathways involved in polymyxininduced apoptotic death in rat kidney proximal tubular cells. The data presented advance our understanding of polymyxin-induced nephrotoxicity.
(Part of this study was presented at the 23rd ECCMID 2013, 27 to 30 April 2013, Berlin, Germany.)
MATERIALS AND METHODS

Chemicals.
Polymyxin B (catalogue number 81334) (Ն6,500 IU/mg) and staurosporine were purchased from Sigma-Aldrich (Australia). A stock solution of 40 mM polymyxin B in Milli-Q water was prepared and sterilized by the use of a 0.22-m-pore-size syringe filter (Millex-GV;Millipore). Staurosporine stock solution (1.0 mM) was prepared in sterile dimethyl sulfoxide (DMSO) (American Type Culture Collection [ATCC], USA).
used to count the cells with filamentous (normal morphology) and/or fragmented (stressed morphology) mitochondria, and counts were expressed as a percentage of the total cell count. At least 50 cells were counted for each treatment (21, 23) .
Evaluation of mitochondrial membrane potential and mitochondrial superoxide formation. NRK-52E cells were treated with 0.25, 0.5, and 1.0 mM polymyxin B for 24 h. For evaluation of time-dependent superoxide formation, cells were treated with 1.0 mM polymyxin B for 0, 4, 8, and 24 h. After treatment, the cells were washed and changes in the mitochondrial membrane potential (⌬⌿) were evaluated by incubating the cells in the dark with 50 nM tetramethylrhodamine ethyl ester (TMRE; Invitrogen) for 30 min at 37°C (24) . TMRE fluorescence was detected at Ex/Em 561/568 to 690 nm. To assess the formation of mitochondrial superoxides, the cells were incubated with 5.0 M MitoSOX Red dye (Invitrogen, Australia) (Ex/Em 514/531 to 622 nm) for 45 min at 37°C (25) . Nuclei were stained with 2 g/ml of Hoechst 33342 (Invitrogen) (Ex/Em 405/410 to 551 nm) to count the cell number. The fluorescence intensity was quantified by laser scanning microscopy (LSM 780 microscope equipped with Plan-Apochromat 20ϫ/0.8 M27 objective and ZEN 2011 software; Carl Zeiss, Germany). The average fluorescence intensity per cell for each treatment was calculated using ImageJ (21, 26) . Averages of at least 75 cells per field and 3 fields per condition were analyzed.
All experiments were conducted as three replicates, and results are presented as means Ϯ standard deviations (SD). Statistical analyses were performed using one-way analysis of variance (ANOVA) and Tukey's test with a significance level (P) of Ͻ0.05 using GraphPad Prism 6.
RESULTS
Polymyxin-induced activation of caspase-3, -8, and -9. Activation of the caspase cascade is a key event during apoptosis (23) . Concentration-dependent activation of caspase-3, -8, and -9 was observed following polymyxin B treatment for 24 h (Fig. 1) . With 1.0 mM polymyxin B, activation of caspase-3 and -8 was increased approximately 4.5-and 3.6-fold, respectively, compared to the untreated control results, whereas the increase of caspase-9 activation was only 1.9-fold.
Polymyxin-induced expression of FasL. A key component in the death receptor-mediated apoptosis pathway is the expression of plasma membrane-anchored FasL (18) . Our results show that polymyxin B treatment caused concentration-and time-dependent expression of FasL (Fig. 2) . The proportion of FasL-positive cells increased to 33.7% Ϯ 6.6% following treatment with 1.0 mM polymyxin B for 24 h, whereas treatment with 2.0 mM polymyxin B for 24 h increased FasL expression to 91.7% Ϯ 9.0% (Fig. 2a) . The proportions of FasL-positive cells after treatment with 1.0 and 2.0 mM polymyxin B for 4 h were 8.6% Ϯ 1.6% and 16.5% Ϯ 0.8%, respectively; these proportions increased to 51.0% Ϯ 13.1% and 92.9% Ϯ 7.8% at 24 h. In addition, we examined the time course (0, 4, 8, and 24 h) of FasL expression in response to treatment with 1.0 and 2.0 mM polymyxin B (Fig. 2b) . The percentage of FasL-positive cells increased over time and was most pronounced at the 24-h time point. The levels of FasL expression were also significantly greater at the 8-and 24-h time points for the higher-concentration (2.0 mM) polymyxin B treatment than for the lower-concentration (1.0 mM) treatment (Fig. 2b) .
Polymyxin-induced mitochondrial morphology fragmentation. Changes in mitochondrial morphology are highly correlated with the functional state of cells and have been shown to be a key apoptotic event (27, 28) . Polymyxin B induced a transition of mitochondrial morphology from filamentous (normal morphology) to fragmented (stressed morphology) in a concentrationand time-dependent manner (Fig. 3) . In a concentration-depen-dent manner at a fixed time point, decreases in the numbers of cells with filamentous mitochondria (56.2% Ϯ 9.7% for 1.0 mM polymyxin B and 30.7% Ϯ 7.5% for 2.0 mM polymyxin B after 8 h) were observed following polymyxin B treatment. In a timedependent manner at a fixed polymyxin B concentration, the proportion of cells with fragmented mitochondria after treatment with 1.0 mM polymyxin B was 24.9% Ϯ 5.0% at 8 h, whereas this proportion increased to 55.8% Ϯ 9.3% at 24 h (Fig. 3c) .
Polymyxin-induced loss of mitochondrial membrane potential and formation of mitochondrial superoxide. Loss of mitochondrial membrane potential and oxidative stress are important indicators of mitochondrial stress during apoptosis (28) . Polymyxin B treatment led to a concentration-dependent loss of mitochondrial membrane potential as evidenced by a decrease in TMRE fluorescence intensity (14.1% Ϯ 2.9% with 1.0 mM polymyxin B compared to the untreated control results) (Fig. 4a) . At the same polymyxin B concentration, there was a concomitant increase of mitochondrial superoxide formation as evidenced by a significant increase of MitoSOX red fluorescence intensity (345% Ϯ 21% relative to the control cell results) (Fig. 4b) . We also followed the time course (0, 4, 8, and 24 h) of MitoSOX red fluorescence in response to treatment with 1.0 mM polymyxin B (Fig.  4c) . After polymyxin B treatment for 4 h, the fluorescence intensity was 123.6% Ϯ 21.2% (relative to the control cell results) whereas the intensity increased to 333.0% Ϯ 13.8% after 24 h of treatment.
DISCUSSION
Polymyxin-induced nephrotoxicity is the major dose-limiting factor hindering its optimal clinical use. We have previously shown that polymyxin-induced nephrotoxicity is associated with apoptosis in kidney tubular cells (29) (30) (31) . Therefore, rat kidney proximal tubular cells (NRK-52E) were employed in the present study. Apoptosis, also known as programmed cell death, is generally mediated through the activation of the caspase-dependent cascade, which is triggered via extrinsic and/or intrinsic stimuli (32) . With extrinsic stimuli, activation of the death receptor pathway triggers apoptotic death (33-35), whereas, with intrinsic stimuli, the mitochondrial pathway leads to the release of apoptogenic factors into the cytoplasm which then trigger downstream events leading to apoptosis (36) . Both of these pathways culminate in a final cellular insult, namely, caspase-dependent DNA fragmentation, which eventuates as apoptotic cell death (37) . The aim of the present study was to investigate the involvement of these key apoptotic signaling pathways in polymyxin-induced apoptosis of kidney tubular cells.
As a first step, we proceeded to confirm that polymyxin B induces activation of caspase-3, -8, and -9 in a concentration-depen- , and caspase-9 (c) was measured using the caspase-selective fluorogenic substrates (see Materials and Methods). Scale bar, 20 m. Group results are presented as means Ϯ SD (n ϭ 3). *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001 (compared with control samples). dent manner (Fig. 1) . Activation of caspase-3 (4.5-fold increase compared to control results) and caspase-8 (3.6-fold increase) was more pronounced than that of caspase-9 (1.9-fold increase). Activation of caspase-8, one of the initiator caspases, is triggered by the extrinsic death receptor pathway (17) . Caspase-9, the other initiator caspase, is mainly activated through proapoptotic proteins released via the intrinsic mitochondrial pathway (38) . The activation of these initiator caspases culminates in the activation of the downstream caspase-3, which is the major executioner caspase during the demolition phase of apoptosis (37) . Thus, our results point to the involvement of both the death receptor and mitochondrial pathways in polymyxin-induced apoptotic kidney tubular cell death. The more pronounced activation of caspase-8 suggests a primary involvement of the death receptor pathway as the apoptotic trigger due to polymyxin treatment. However, this does not discount the involvement of the mitochondrial pathway, as it should be noted that the death receptor-activated caspase, caspase-8, can also induce the release of the mitochondrial proapoptotic proteins that activate caspase-9 (39, 40) .
Having definitively established a link between polymyxin-induced kidney tubular cell death and apoptosis, we proceeded to investigate the involvement of the extrinsic (death receptor) and intrinsic (mitochondrial) apoptotic trigger pathways. In the extrinsic death receptor pathway, Fas (syn., death receptor), a 37-kDa type-I transmembrane glycoprotein, acts as a module for interaction with FasL (18) . Binding of FasL to Fas triggers the activation of the initiator caspase-8, which subsequently activates the executioner caspase-3, leading to apoptotic cell death (33) . FasL expression has been shown to be involved in drug-induced apoptosis in several tissues, including the kidney (41). Notably, treatment of patients with cisplatin, the nephrotoxic anticancer drug, induced the expression of FasL in kidney tubular cells (42) . In the present study, FACS analysis revealed that polymyxin B induced the expression of FasL in rat kidney tubular cells in a concentration-and time-dependent manner (Fig. 2) . Taken together, our results clearly demonstrate the association between the activation of caspase-8 and the death receptor pathway during polymyxin-induced apoptosis.
In the intrinsic mitochondrial pathway, the stimuli triggers cytochrome c release from the mitochondrial intermembrane space (40) . After release, cytochrome c binds to apoptosis protease activating factor 1 (APAF-1) and pro-caspase-9 to form apoptosome, which promotes the activation of caspase-9, which in turn activates the executioner caspase-3 (43). Our results indicated that polymyxin-induced kidney tubular apoptotic cell death is associated with caspase-9 activation, pointing to the involvement of the mitochondrial pathway. It has been shown that mitochondrial stress during apoptosis not only involves cytochrome c release but also is associated with a massive remodelling of the mitochondrial ultrastructure (27, 44) . In healthy kidney tubular cells, mitochondria predominantly adopt a filamentous morphology (23, 45) , whereas, in cells undergoing apoptotic cell death, mitochondria adopt a fragmented morphology (23, 45) . Polymyxin B induced a concentration-and time-dependent transition of the mitochondrial morphology from filamentous (normal) to fragmented (stressed) (Fig. 3) . Mitochondrial morphology changes are associated with a loss of mitochondrial membrane potential (⌬), an indication of mitochondrial dysfunction (45) . Polymyxin B also induced a concentration-dependent loss of ⌬ (Fig. 4) . Furthermore, we observed the generation of reactive oxygen species (ROS) in polymyxin-treated kidney tubular cells, a phenomenon that has been associated with apoptotic mitochondrial morphology changes (46) . These findings are in line with our previous studies which showed that antioxidants can act to attenuate polymyxin-induced nephrotoxicity in rats (30, 31, 47) . The present results support the notion of a need for evaluation of the possible role of antioxidants to ameliorate polymyxin-induced nephrotoxicity in patients. To the best of our knowledge, this is the first study to have revealed that polymyxin-induced apoptosis in cultured kidney tubular cells is mediated by both the extrinsic death receptor and intrinsic mitochondrial pathways. We present a putative model for polymyxin-induced apoptosis in kidney proximal tubular cells (Fig. 5) . Similar to the findings from a mouse study (31) , our cell culture results also suggest that there are interactions between the death receptor and mitochondrial pathways in NRK-52E cells, as activation of both caspase-8 and -9 was observed in the polymyxin-treated cells. This could partly be explained by the capacity of activated casapse-8 (using the death receptor pathway) to cleave Bid, a mitochondrial interacting BcL-2 protein, to produce tBid, which triggers the mitochondrial apoptotic pathway (39) . Very recently, activation of tBid was reported in mice treated with 7.5 and 15 mg of colistin/kg of body weight/day for 7 days (31). To conclude, our findings shed new light on the cellular death pathways that mediate polymyxin-induced nephrotoxicity and may benefit development of novel strategies for the effective and safe clinical use of this important last-line class of antibiotics. 
